This research goals to research the position of miR-495 in neuronal cell apoptosis after acute spinal cord injury (ASCI). The ASCI rat mannequin was established and the Basso, Beattie, and Bresnahan (BBB) rating was assessed. miR-495, PR area containing 5 (PRDM5), and Bcl-2 expressions have been measured by qRT-PCR or western blotting. Neuronal cell line PC-12 was subjected to hypoxia situation to simulate the in vitro ASCI mannequin. PC-12 cell apoptosis was measured by movement cytometry, and the interplay between miR-495 and PRDM5 was confirmed by twin luciferase reporter assay.
Results confirmed that BBB rating was considerably decreased in ASCI rats in contrast with sham rats. miR-495 expression was down-regulated in spinal cord tissue of ASCI rats and hypoxia-induced PC-12 cells, and PRDM5 protein stage was up-regulated in spinal cord tissue of ASCI rats and hypoxia-induced PC-12 cells. miR-495 overexpression may cut back apoptosis of PC-12 cells, and up-regulated anti-apoptosis protein Bcl-2 protein stage.
Moreover, PRDM5 was a goal of miR-495, and mRNA and protein ranges of PRDM5 have been negatively regulated by miR-495. miR-495 overexpression may cut back the hypoxia-induced PC-12 cell apoptosis, whereas PRDM5 overexpression abolished this inhibiting impact. The agomir-495 was injected into ASCI rats, and Bcl-2 protein stage and BBB rating have been elevated, however the PRDM5 overexpression reversed these outcomes. Overall, we concluded that miR-495 may inhibit neuronal cell apoptosis and relieve acute spinal cord injury through inhibiting PRDM5.
Second-Order Orbital Optimization with Large Active Spaces Using Adaptive Sampling Configuration Interaction (ASCI) and Its Application to Molecular Geometry Optimization
Recently, chosen configuration interplay (SCI) strategies that allow calculations with a number of tens of lively orbitals have been developed. With the SCI subspace embedded within the imply area, molecular orbitals with an accuracy akin to that of the whole lively area self-consistent area methodology will be obtained. Here, we implement the analytical gradient concept for the single-state adaptive sampling CI (ASCI) SCF methodology to allow molecular geometry optimization.
The ensuing analytical gradient is inherently approximate because of the dependence on the sampled determinants, however its accuracy was adequate for performing geometry optimizations with giant lively areas. To acquire the tight convergence wanted for correct analytical gradients, we mix the augmented Hessian (AH) and Werner-Meyer-Knowles (WMK) second-order orbital optimization strategies with the ASCI-SCF methodology. We take a look at these algorithms for orbital and geometry optimizations, display functions of the geometry optimizations of polyacenes and periacenes, and talk about the geometric dependence of the traits of singlet ASCI wave features.
First report of Erysiphe corylacearum, agent of powdery mildew, on hazelnut ( Corylus avellana) in Romania
Romania has an space devoted to hazelnut (Corylus avellana L.), protecting 890 hectares as of 2019. During October 2020, powdery mildew signs have been noticed on the higher facet of leaves of hazelnut ‘Tonda di Giffoni’ in two business orchards in Dudeștii Vechi, Romania (Fig. 1). The illness was current on 70% of the bushes in planting, with no less than 5 leaves per tree having powdery mildew. Micromorphological examination revealed amphigenous, hyaline, branched, septate mycelial patches of two.
Three to three.6 μm in diameter. Conidiophores measured 24-60 × 5-6 (common: 45 × 6) μm and consisted of erect, cylindrical to flexuous foot cells, adopted by 1-2 shorter cells. Ellipsoid, ovoid to doliform conidia have been produced singly and they measured 19-35 × 16-24 (common: 28 × 19) μm. Chasmothecia have been spherical, 75 to 107 (common: 88) μm in diameter. Nine to 13 straight, generally flexuous, appendages measured 54 to 92 (common: 66) μm in size and that they had 5 occasions dichotomous branched apices with curved suggestions (Fig. 2). Each chasmothecium contained three to 5 ellipsoid, ovoid to subglobose asci measuring 41-58 × 29-55 μm (common 52 × 43) μm.
The asci contained 4 to eight ascospores measuring 13-24 × 11-15 (common 18 × 14) μm. Morphological identification was confirmed by sequencing the ITS-region of rDNA utilizing two isolates from leaves, saved as frozen mycelium at -20°C. PCR was carried out with Erysiphales-specific primer pair PMITS1/PMITS2 (Cunnington et al. 2003). The obtained sequences have been deposited in GenBank (Accession n° MW423075, MW423076).
Blast evaluation of each sequences had 100% identification to ITS rDNA sequences of Erysiphe corylacearum from Azerbaijan (Abasova et al. 2018; Accession n° LC270863), Turkey (Sezer et al. 2017; KY082910), Switzerland (Beenken et al. 2020; MN82272), Iran (Arzanlou et al. 2018; MH047243), Italy (Mezzalama et al. 2020; MW045425) and 99% identification from Georgia (Meparishvili et al. 2019; MK157199).
The sequences had a decrease % identification (83%) to Phyllactinia guttata (Accession n° AB080558) (Fig. 3). Pathogenicity was verified on one-year-old vegetation of C. avellana ‘Tonda di Giffoni’, which have been artificially inoculated with a conidial suspension from contaminated leaves (n = 25). Inoculated vegetation have been incubated at 20 to 28°C with 70 to 80% relative humidity.
White mycelium appeared on the higher floor of the leaves at eight to 10 days after inoculation. No signs have been discovered on management vegetation sprayed with sterile water. The fungus current on inoculated leaves was morphologically an identical to the unique isolates from diseased bushes from the sector. E. corylacearum is native to East Asia and was beforehand reported in Japan on wild species of Corylus (Takamatsu et al. 2015; Accession n° LC009928).
The pathogen more than likely unfold into Europe from east to west of Europe (Heluta et al. 2019), through the Caucasus, ranging from Turkey, Azerbaijan, Georgia, and Iran. P. guttata was thought of the one causal agent of powdery mildew on hazelnut in most international locations, together with Romania (Brown 1995). Compared to P. guttata, which typically develops a mycelium on the underside of leaves, E. corylacearum grows with a white mycelium on the higher facet of the leaves.
 TNN Antibody |
|||
| 1-CSB-PA775994 | Cusabio |
|
|
|
Description: A polyclonal antibody against TNN. Recognizes TNN from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:3000-1:10000, IHC:1:50-1:200 |
|||
TNN Antibody |
|||
| GWB-MW809H | GenWay Biotech | 50ug | Ask for price |
TNN Antibody |
|||
| E037267 | EnoGene | 100μg/100μl | 255 EUR |
|
Description: Available in various conjugation types. |
|||
TNN Antibody |
|||
| E40PV3999 | EnoGene | 50ul | 395 EUR |
|
Description: Available in various conjugation types. |
|||
TNN Antibody |
|||
| MBS7110555-005mg | MyBiosource | 0.05mg | 190 EUR |
TNN Antibody |
|||
| MBS7110555-01mg | MyBiosource | 0.1mg | 270 EUR |
TNN Antibody |
|||
| MBS7110555-5x01mg | MyBiosource | 5×0.1mg | 1205 EUR |
TNN Antibody |
|||
| MBS7128236-005mL | MyBiosource | 0.05mL | 190 EUR |
TNN Antibody |
|||
| MBS7128236-01mL | MyBiosource | 0.1mL | 270 EUR |
TNN Antibody |
|||
| MBS7128236-5x01mL | MyBiosource | 5×0.1mL | 1205 EUR |
TNN Antibody |
|||
| MBS7128237-005mL | MyBiosource | 0.05mL | 190 EUR |
TNN Antibody |
|||
| MBS7128237-01mL | MyBiosource | 0.1mL | 270 EUR |
TNN Antibody |
|||
| MBS7128237-5x01mL | MyBiosource | 5×0.1mL | 1205 EUR |
TNN Antibody |
|||
| MBS9401195-01mL | MyBiosource | 0.1mL | 305 EUR |
TNN Antibody |
|||
| MBS9401195-5x01mL | MyBiosource | 5×0.1mL | 1230 EUR |
) TNN Antibody (Center) |
|||
| MBS9201489-008mL | MyBiosource | 0.08mL | 210 EUR |
TNN Antibody (Center) |
|||
| MBS9201489-04mL | MyBiosource | 0.4mL | 430 EUR |
TNN Antibody (Center) |
|||
| MBS9201489-5x04mL | MyBiosource | 5×0.4mL | 1910 EUR |
 TNN Polyclonal Antibody |
|||
| E-AB-16087-120uL | Elabscience Biotech | 120uL | 240 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-16087-200uL | Elabscience Biotech | 200uL | 399 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-16087-20uL | Elabscience Biotech | 20uL | 73 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-16087-60uL | Elabscience Biotech | 60uL | 143 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-12897-120uL | Elabscience Biotech | 120uL | 240 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-12897-200uL | Elabscience Biotech | 200uL | 399 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-12897-20uL | Elabscience Biotech | 20uL | 73 EUR |
|
Description: Unconjugated |
|||
TNN Polyclonal Antibody |
|||
| E-AB-12897-60uL | Elabscience Biotech | 60uL | 143 EUR |
|
Description: Unconjugated |
|||
 TNN Conjugated Antibody |
|||
| C37267 | SAB | 100ul | 476.4 EUR |
TNN Polyclonal Antibody |
|||
| MBS2521434-002mL | MyBiosource | 0.02mL | 135 EUR |
TNN Polyclonal Antibody |
|||
| MBS2521434-006mL | MyBiosource | 0.06mL | 190 EUR |
TNN Polyclonal Antibody |
|||
| MBS2521434-012mL | MyBiosource | 0.12mL | 265 EUR |
TNN Polyclonal Antibody |
|||
| MBS2521434-02mL | MyBiosource | 0.2mL | 415 EUR |
TNN Polyclonal Antibody |
|||
| MBS2521434-5x02mL | MyBiosource | 5×0.2mL | 1835 EUR |
TNN Polyclonal Antibody |
|||
| MBS2527133-002mL | MyBiosource | 0.02mL | 135 EUR |
TNN Polyclonal Antibody |
|||
| MBS2527133-006mL | MyBiosource | 0.06mL | 190 EUR |
TNN Polyclonal Antibody |
|||
| MBS2527133-012mL | MyBiosource | 0.12mL | 265 EUR |
TNN Polyclonal Antibody |
|||
| MBS2527133-02mL | MyBiosource | 0.2mL | 415 EUR |
TNN Polyclonal Antibody |
|||
| MBS2527133-5x02mL | MyBiosource | 5×0.2mL | 1835 EUR |
TNN Conjugated Antibody |
|||
| MBS9447710-01mLAF350 | MyBiosource | 0.1mL(AF350) | 480 EUR |
TNN Conjugated Antibody |
|||
| MBS9447710-01mLAF405 | MyBiosource | 0.1mL(AF405) | 480 EUR |
TNN Conjugated Antibody |
|||
| MBS9447710-01mLAF488 | MyBiosource | 0.1mL(AF488) | 480 EUR |
TNN Conjugated Antibody |
|||
| MBS9447710-01mLAF555 | MyBiosource | 0.1mL(AF555) | 480 EUR |
TNN Conjugated Antibody |
|||
| MBS9447710-01mLBiotin | MyBiosource | 0.1mL(Biotin) | 480 EUR |
TNN Polyclonal Antibody |
|||
| RD78781A-120uL | Reddot Biotech | 120μL | 360 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD78781A-200uL | Reddot Biotech | 200μL | 630 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD78781A-20uL | Reddot Biotech | 20μL | 109.5 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD78781A-60uL | Reddot Biotech | 60μL | 214.5 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD76582A-120uL | Reddot Biotech | 120μL | 360 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD76582A-200uL | Reddot Biotech | 200μL | 630 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD76582A-20uL | Reddot Biotech | 20μL | 109.5 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
TNN Polyclonal Antibody |
|||
| RD76582A-60uL | Reddot Biotech | 60μL | 214.5 EUR |
|
Description: This protein is involved in neurite outgrowth and cell migration in hippocampal explants.It has three EGF-like domains, one fibrinogen C-terminal domain and nine fibronectin type III domains.Tenascins are extracellular matrix proteins present during the development of organisms as well as in pathological conditions.Tenascin-W, the fourth and last member of the tenascin family remains the least well-characterized one. |
|||
 Anti-TENN TNN Antibody |
|||
| A05722 | BosterBio | 100ul | 380 EUR |
|
Description: Boster Bio Anti-TENN TNN Antibody catalog # A05722. Tested in ELISA, WB applications. This antibody reacts with Human, Mouse. |
|||
 Antibody) Tenascin-N (TNN) Antibody |
|||
| abx027503-400l | Abbexa | 400 µl | 518.75 EUR |
Tenascin-N (TNN) Antibody |
|||
| abx027503-400ul | Abbexa | 400 ul | 627.6 EUR |
Tenascin-N (TNN) Antibody |
|||
| abx027503-80l | Abbexa | 80 µl | 250 EUR |
Tenascin-N (TNN) Antibody |
|||
| abx213586-100g | Abbexa | 100 µg | 250 EUR |
Tenascin-N (TNN) Antibody |
|||
| 20-abx213586 | Abbexa |
|
|
Tenascin-N (TNN) Antibody |
|||
| abx213587-100g | Abbexa | 100 µg | 250 EUR |
Tenascin-N (TNN) Antibody |
|||
| 20-abx213587 | Abbexa |
|
|
Tenascin-N (TNN) Antibody |
|||
| abx349685-96tests | Abbexa | 96 tests | 162.5 EUR |
 TNN Antibody, HRP conjugated |
|||
| 1-CSB-PA892498LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against TNN. Recognizes TNN from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
TNN Antibody, HRP conjugated |
|||
| MBS7110556-005mg | MyBiosource | 0.05mg | 190 EUR |
TNN Antibody, HRP conjugated |
|||
| MBS7110556-01mg | MyBiosource | 0.1mg | 270 EUR |
TNN Antibody, HRP conjugated |
|||
| MBS7110556-5x01mg | MyBiosource | 5×0.1mg | 1205 EUR |
 TNN Antibody, FITC conjugated |
|||
| 1-CSB-PA892498LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against TNN. Recognizes TNN from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
TNN Antibody, FITC conjugated |
|||
| MBS7110557-005mg | MyBiosource | 0.05mg | 190 EUR |
TNN Antibody, FITC conjugated |
|||
| MBS7110557-01mg | MyBiosource | 0.1mg | 270 EUR |
TNN Antibody, FITC conjugated |
|||
| MBS7110557-5x01mg | MyBiosource | 5×0.1mg | 1205 EUR |
 TNN Antibody, Biotin conjugated |
|||
| 1-CSB-PA892498LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against TNN. Recognizes TNN from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
TNN Antibody, Biotin conjugated |
|||
| MBS7110558-005mg | MyBiosource | 0.05mg | 190 EUR |
TNN Antibody, Biotin conjugated |
|||
| MBS7110558-01mg | MyBiosource | 0.1mg | 270 EUR |
TNN Antibody, Biotin conjugated |
|||
| MBS7110558-5x01mg | MyBiosource | 5×0.1mg | 1205 EUR |
 Antibody (HRP)) Tenascin-N (TNN) Antibody (HRP) |
|||
| abx349686-96tests | Abbexa | 96 tests | 162.5 EUR |
 Antibody (FITC)) Tenascin-N (TNN) Antibody (FITC) |
|||
| abx349687-96tests | Abbexa | 96 tests | 162.5 EUR |
 Antibody (Biotin)) Tenascin-N (TNN) Antibody (Biotin) |
|||
| abx349688-96tests | Abbexa | 96 tests | 162.5 EUR |
 TNN antibody – N-terminal region |
|||
| MBS3215924-01mL | MyBiosource | 0.1mL | 455 EUR |
TNN antibody – N-terminal region |
|||
| MBS3215924-5x01mL | MyBiosource | 5×0.1mL | 1995 EUR |
 TNN Rabbit Polyclonal Antibody |
|||
| E10G04486 | EnoGene | 100 μl | 275 EUR |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
TNN Rabbit Polyclonal Antibody |
|||
| E10G11376 | EnoGene | 100 μl | 275 EUR |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
 Blocking peptide) TNN Antibody (Center) Blocking peptide |
|||
| MBS9220054-INQUIRE | MyBiosource | INQUIRE | Ask for price |
 Polyclonal TNN antibody – N-terminal region |
|||
| AMM08262G | Leading Biology | 0.05mg | 633.6 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TNN – N-terminal region. This antibody is tested and proven to work in the following applications: |
|||
 OAAB09919-400UL – TNN Antibody – middle region |
|||
| OAAB09919-400UL | Aviva Systems Biology | 400ul | 389 EUR |
 Anti-Human TNN/Tenascin-N Antibody |
|||
| MBS1569297-01mg | MyBiosource | 0.1mg | 405 EUR |
Anti-Human TNN/Tenascin-N Antibody |
|||
| MBS1569297-5x01mg | MyBiosource | 5×0.1mg | 1520 EUR |
 ARP63200_P050-25UL – TNN Antibody – N-terminal region |
|||
| ARP63200_P050-25UL | Aviva Systems Biology | 25ul | 99 EUR |
) ARP63200_P050 – TNN antibody – N-terminal region (ARP63200_P050) |
|||
| ARP63200_P050 | Aviva Systems Biology | 100ul | 389 EUR |
) TNN, ID (TNN, Tenascin-N) |
|||
| MBS6010844-02mL | MyBiosource | 0.2(mL | 695 EUR |
TNN, ID (TNN, Tenascin-N) |
|||
| MBS6010844-5x02mL | MyBiosource | 5×0.2mL | 2975 EUR |
 (AP)) TNN, ID (TNN, Tenascin-N) (AP) |
|||
| MBS6357197-02mL | MyBiosource | 0.2mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (AP) |
|||
| MBS6357197-5x02mL | MyBiosource | 5×0.2mL | 4250 EUR |
 (PE)) TNN, ID (TNN, Tenascin-N) (PE) |
|||
| MBS6357207-02mL | MyBiosource | 0.2mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (PE) |
|||
| MBS6357207-5x02mL | MyBiosource | 5×0.2mL | 4250 EUR |
 (APC)) TNN, ID (TNN, Tenascin-N) (APC) |
|||
| MBS6357198-02mL | MyBiosource | 0.2mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (APC) |
|||
| MBS6357198-5x02mL | MyBiosource | 5×0.2mL | 4250 EUR |
 (FITC)) TNN, ID (TNN, Tenascin-N) (FITC) |
|||
| MBS6357200-02mL | MyBiosource | 0.2mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (FITC) |
|||
| MBS6357200-5x02mL | MyBiosource | 5×0.2mL | 4250 EUR |
 (Biotin)) TNN, ID (TNN, Tenascin-N) (Biotin) |
|||
| MBS6357199-02mL | MyBiosource | 0.2mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (Biotin) |
|||
| MBS6357199-5x02mL | MyBiosource | 5×0.2mL | 4250 EUR |
-Human tenascin N (TNN)) TNN (untagged)-Human tenascin N (TNN) |
|||
| SC304989 | Origene Technologies GmbH | 10 µg | Ask for price |
 (MaxLight 405)) TNN, ID (TNN, Tenascin-N) (MaxLight 405) |
|||
| MBS6357202-01mL | MyBiosource | 0.1mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (MaxLight 405) |
|||
| MBS6357202-5x01mL | MyBiosource | 5×0.1mL | 4250 EUR |
 (MaxLight 490)) TNN, ID (TNN, Tenascin-N) (MaxLight 490) |
|||
| MBS6357203-01mL | MyBiosource | 0.1mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (MaxLight 490) |
|||
| MBS6357203-5x01mL | MyBiosource | 5×0.1mL | 4250 EUR |
 (MaxLight 550)) TNN, ID (TNN, Tenascin-N) (MaxLight 550) |
|||
| MBS6357204-01mL | MyBiosource | 0.1mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (MaxLight 550) |
|||
| MBS6357204-5x01mL | MyBiosource | 5×0.1mL | 4250 EUR |
 (MaxLight 650)) TNN, ID (TNN, Tenascin-N) (MaxLight 650) |
|||
| MBS6357205-01mL | MyBiosource | 0.1mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (MaxLight 650) |
|||
| MBS6357205-5x01mL | MyBiosource | 5×0.1mL | 4250 EUR |
 (MaxLight 750)) TNN, ID (TNN, Tenascin-N) (MaxLight 750) |
|||
| MBS6357206-01mL | MyBiosource | 0.1mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (MaxLight 750) |
|||
| MBS6357206-5x01mL | MyBiosource | 5×0.1mL | 4250 EUR |
 - Mouse tenascin N (Tnn), (10ug)) Tnn (untagged) – Mouse tenascin N (Tnn), (10ug) |
|||
| MC224688 | Origene Technologies GmbH | 10 µg | Ask for price |
 Anti-TNN Antibody, Rabbit Polyclonal |
|||
| MBS8109289-01mL | MyBiosource | 0.1mL | 300 EUR |
Anti-TNN Antibody, Rabbit Polyclonal |
|||
| MBS8109289-5x01mL | MyBiosource | 5×0.1mL | 1200 EUR |
 Anti-TNN Rabbit Polyclonal Antibody |
|||
| TA322208 | Origene Technologies GmbH | 100 µl | Ask for price |
Anti-TNN Rabbit Polyclonal Antibody |
|||
| TA322209 | Origene Technologies GmbH | 100 µl | Ask for price |
 (Azide free) (HRP)) TNN, ID (TNN, Tenascin-N) (Azide free) (HRP) |
|||
| MBS6357201-02mL | MyBiosource | 0.2mL | 980 EUR |
TNN, ID (TNN, Tenascin-N) (Azide free) (HRP) |
|||
| MBS6357201-5x02mL | MyBiosource | 5×0.2mL | 4250 EUR |
 - Rat tenascin N (Tnn), (10 ug)) Tnn (untagged ORF) – Rat tenascin N (Tnn), (10 ug) |
|||
| RN201535 | Origene Technologies GmbH | 10 µg | Ask for price |
 Mouse TNN siRNA |
|||
| 20-abx937676 | Abbexa |
|
|
 Human TNN siRNA |
|||
| 20-abx937677 | Abbexa |
|
|
) TNN siRNA (Human) |
|||
| MBS8223702-15nmol | MyBiosource | 15nmol | 405 EUR |
TNN siRNA (Human) |
|||
| MBS8223702-30nmol | MyBiosource | 30nmol | 565 EUR |
Recently, E. corylacearum on C. avellana was reported additionally in Ukraine (Heluta et al. 2019), from which it may have moved to Romania. Crop safety methods for hazelnut must be revised in line with the brand new pathogen prevalence.